发明名称 Processes for the preparation of highly pure Rivaroxaban crystal modification I
摘要 Provided herein are improved, commercially viable and consistently reproducible processes for the preparation of highly pure crystal Modification I of Rivaroxaban, which is free from other polymorphs and undesired solvated forms. Provided also herein is a highly pure and stable crystal Modification I of Rivaroxaban essentially free of other solid state forms.
申请公布号 US9469628(B2) 申请公布日期 2016.10.18
申请号 US201514601419 申请日期 2015.01.21
申请人 Symed Labs Limited 发明人 Dodda Mohan Rao;Bingi Venugopal
分类号 C07D413/14 主分类号 C07D413/14
代理机构 Caesar Rivise, PC 代理人 Caesar Rivise, PC
主权项 1. A process for the preparation of Crystal Modification I of Rivaroxaban, comprising: a) providing a solution of Rivaroxaban in a solvent medium comprising water and acetone at an ambient temperature; b) optionally, subjecting the solution obtained in step-(a) to carbon treatment to obtain a filtrate; c) cooling the solution obtained in step-(a) or step-(b) at a temperature of below about 35° C. to cause crystallization; and d) recovering highly pure crystal Modification I of Rivaroxaban formed in step-(c).
地址 IN